Consolidated Balance Sheets - USD ($)	Sep. 30, 2017	Dec. 31, 2016
Successor [Member]
ASSETS
Cash	$ 360,871
Prepaid expense and deposits	890,629
Inventory	45,000
Assets held for discontinued operations	120,768
Total Current Assets	1,417,268
Equipment	82,388
Intangible asset	250,000
Assets held for discontinued operations	2,594,107
Total Assets	4,343,763
Current Liabilities
Accounts payable and accrued liabilities	25,678
Due to related parties	10,000
Convertible notes, net of discount of $283,886	50,026
Liabilities held for discontinued operations	47,197
Total Current Liabilities	132,901
Liabilities held for discontinued operations	652,836
Total Liabilities	785,737
SHAREHOLDERS' EQUITY
Preferred Stock, 9,980,000 shares authorized, $0.001 par value; no shares issued and outstanding	0
Common stock, 500,000,000 shares authorized, par value $0.01; 20,243,429 shares outstanding (December 31, 2016 - 9,681,929 shares outstanding)	206,531
Additional paid-in capital	8,650,031
Accumulated deficit	(5,298,536)
Total Corix Bioscience, Inc.'s Shareholders' Equity	3,558,026
Non-controlling interest	0
Total Shareholders' Equity	3,558,026
Total Liabilities and Shareholders' Equity	4,343,763
Predecessor [Member]
ASSETS
Cash		$ 2,151
Prepaid expense and deposits		24,125
Inventory		0
Assets held for discontinued operations		211,558
Total Current Assets		237,834
Equipment		4,592
Intangible asset		0
Assets held for discontinued operations		11,127,246
Total Assets		11,369,672
Current Liabilities
Accounts payable and accrued liabilities		65,788
Due to related parties		407,728
Convertible notes, net of discount of $283,886		0
Liabilities held for discontinued operations		600,466
Total Current Liabilities		1,073,982
Liabilities held for discontinued operations		4,690,077
Total Liabilities		5,764,059
SHAREHOLDERS' EQUITY
Preferred Stock, 9,980,000 shares authorized, $0.001 par value; no shares issued and outstanding		0
Common stock, 500,000,000 shares authorized, par value $0.01; 20,243,429 shares outstanding (December 31, 2016 - 9,681,929 shares outstanding)		96,819
Additional paid-in capital		16,803,120
Accumulated deficit		(12,424,339)
Total Corix Bioscience, Inc.'s Shareholders' Equity		4,475,600
Non-controlling interest		1,130,013
Total Shareholders' Equity		5,605,613
Total Liabilities and Shareholders' Equity		11,369,672
Preferred Class A [Member] | Successor [Member]
SHAREHOLDERS' EQUITY
Preferred Stock - Series A, 20,000 shares authorized, $0.001 par value; no shares issued and outstanding	$ 0
Preferred Class A [Member] | Predecessor [Member]
SHAREHOLDERS' EQUITY
Preferred Stock - Series A, 20,000 shares authorized, $0.001 par value; no shares issued and outstanding		$ 0